1. Hepatic Suppression of Mitochondrial Complex II Assembly Drives Systemic Metabolic Benefits.
- Author
-
Wang, Xueqiang, Lv, Weiqiang, Xu, Jie, Zheng, Adi, Zeng, Mengqi, Cao, Ke, Wang, Xun, Cui, Yuting, Li, Hao, Yang, Meng, Shao, Yongping, Zhang, Fang, Zou, Xuan, Long, Jiangang, Feng, Zhihui, and Liu, Jiankang
- Subjects
- *
KREBS cycle , *INSULIN sensitivity , *LOW-calorie diet , *MITOCHONDRIA , *METABOLIC disorders , *LIVER cells - Abstract
Alternate day fasting (ADF), the most popular form of caloric restriction, has shown to improve metabolic health in preclinical subjects, while intrinsic network underpinning the process remains unclear. Here, it is found that liver undergoes dramatic metabolic reprogramming during ADF, accompanied surprisingly with unique complex II dysfunction attributing to suspended complex II assembly via suppressing SDHAF4, a recently identified assembly factor. Despite moderate mitochondrial complex II dysfunction, hepatic Sdhaf4 knockout mice present intriguingly improved glucose tolerance and systemic insulin sensitivity, consistent with mice after ADF intervention. Mechanistically, it is found that hepatocytes activate arginine‐nitric oxide (NO) biosynthesis axle in response to complex II and citric acid cycle dysfunction, the release of NO from liver can target muscle and adipocytes in addition to its autocrine action for enhanced insulin sensitivity. These results highlight the pivotal role of liver in ADF‐associated systemic benefits, and suggest that targeting hepatic complex II assembly can be an intriguing strategy against metabolic disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF